| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |